Role of RLIP76 in lung cancer doxorubicin resistance: III. Anti-RLIP76 antibodies trigger apoptosis in lung cancer cells and synergistically increase doxorubicin cytotoxicity
about
RLIP76, a non-ABC transporter, and drug resistance in epilepsy.The "two-faced" effects of reactive oxygen species and the lipid peroxidation product 4-hydroxynonenal in the hallmarks of cancerTumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancerRole of RLIP76 in lung cancer doxorubicin resistance: II. Doxorubicin transport in lung cancer by RLIP76Autoantibodies to the C-terminal subunit of RLIP76 induce oxidative stress and endothelial cell apoptosis in immune-mediated vascular diseases and atherosclerosis.RLIP76: a versatile transporter and an emerging target for cancer therapy.Emerging treatments in lung cancer - targeting the RLIP76 molecular transporter.Overexpression of RLIP76 Required for Proliferation in Meningioma Is Associated with Recurrence.Overexpression of RalBP1 in colorectal cancer is an independent predictor of poor survival and early tumor relapseHsf-1 and POB1 induce drug sensitivity and apoptosis by inhibiting Ralbp1Antioxidant role of glutathione S-transferases: 4-Hydroxynonenal, a key molecule in stress-mediated signalingRLIP76: A novel glutathione-conjugate and multi-drug transporter.Self-regulatory role of 4-hydroxynonenal in signaling for stress-induced programmed cell death.RLIP76 and Cancer.RLIP76 Targeted Therapy for Kidney CancerRLIP76 increases apoptosis through Akt/mTOR signaling pathway in gastric cancer.Increased expression of cdc2 inhibits transport function of RLIP76 and promotes apoptosis
P2860
Q24533543-B1AD4E86-6958-4A44-AF2A-84060FAE9A4AQ28391375-6FB781D8-2102-4C1B-AAB3-FBAEF262106DQ28396304-99CB694E-17AA-45D1-A457-311AC8857731Q30051796-78EFB638-490A-45A5-A56C-DA2A0254BDA7Q30481778-20B6155D-5A89-4C4C-ACFE-8B18A335F4FDQ33867008-85CDD363-A2DA-415C-936E-470105B88473Q34556062-0C1F30DA-7CE0-4CCB-994D-7304691FC5C8Q35628908-8D21659C-DF52-4B35-95D3-5AFC192F9C24Q36129973-8CAC5DFD-10E9-4139-BF98-EC9D416A68A4Q36744205-98270C84-5706-4FF0-9DC2-A00E11B8DBA0Q36857274-94D5709C-2AA2-4ABD-BCD1-D987CE2E2F08Q37146979-05FE7AEA-A623-4797-A436-A9C569A5AE34Q37154223-3CC4244E-A314-4B06-8EB1-2A652E2FB5E2Q37217140-5B6FC6AF-8305-4D3F-9089-DAC9F0E2669CQ37741408-B258D7E5-4B5E-459F-AF96-EE4BDC3ED0E6Q38749340-55D87CF8-82FF-4AB7-996C-668FEA9FC682Q39859514-77CABF33-D3BD-4EFB-81AF-8DB6B023946E
P2860
Role of RLIP76 in lung cancer doxorubicin resistance: III. Anti-RLIP76 antibodies trigger apoptosis in lung cancer cells and synergistically increase doxorubicin cytotoxicity
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Role of RLIP76 in lung cancer ...... rease doxorubicin cytotoxicity
@ast
Role of RLIP76 in lung cancer ...... rease doxorubicin cytotoxicity
@en
Role of RLIP76 in lung cancer ...... rease doxorubicin cytotoxicity
@nl
type
label
Role of RLIP76 in lung cancer ...... rease doxorubicin cytotoxicity
@ast
Role of RLIP76 in lung cancer ...... rease doxorubicin cytotoxicity
@en
Role of RLIP76 in lung cancer ...... rease doxorubicin cytotoxicity
@nl
prefLabel
Role of RLIP76 in lung cancer ...... rease doxorubicin cytotoxicity
@ast
Role of RLIP76 in lung cancer ...... rease doxorubicin cytotoxicity
@en
Role of RLIP76 in lung cancer ...... rease doxorubicin cytotoxicity
@nl
P2093
P921
P1476
Role of RLIP76 in lung cancer ...... rease doxorubicin cytotoxicity
@en
P2093
Jyotsana Singhal
Piotr Zimniak
Sanjay Awasthi
Sharad S Singhal
Yogesh C Awasthi
Yusong Yang
P304
P407
P577
2003-04-01T00:00:00Z